Ads
related to: simplified hcv treatment algorithm for prostate cancer research charity- Schedule an Appointment
Schedule an Appointment Today
Call our Cancer Answer Line
- Prostate Cancer Treatment
Download our Prostate Cancer Guide
Find Prostate Cancer Treatments
- Virtual Second Opinions
Get Peace of Mind from Home.
Review Your Diagnosis & Treatment.
- Second Opinion
In Need of a Second Opinion?
Our Cancer Answer Line Can Help
- Schedule an Appointment
Search results
Results from the WOW.Com Content Network
Surgical removal of the prostate, or prostatectomy, is a common treatment either for early-stage prostate cancer or for cancer that has failed to respond to radiation therapy. The most common type is radical retropubic prostatectomy , when the surgeon removes the prostate through an abdominal incision.
Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. [8] It is a fixed-dose combination of ledipasvir and sofosbuvir. [8] Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1. [9] Some evidence also supports use in HCV genotype 3 and 4. [9]
The American Institute for Cancer Research (AICR) is a large American cancer research organization associated with the World Cancer Research Fund umbrella organization. As of 2024, the charity has a four-star rating from Charity Navigator , with a score of 96 out of 100.
Mark Scholz (born 1955) is a German-American, double board-certified oncologist and author. He serves as medical director of Prostate Oncology Specialists Inc. in Marina del Rey, CA, a medical practice exclusively focused on prostate cancer.
The hepatitis C virus (HCV) [3] is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphomas in humans. [4] [5]
Prostate Cancer Foundation of Australia is a broad-based community organisation and the peak national body for prostate cancer in Australia.The Foundation is dedicated to reducing the impact of prostate cancer on Australian men, their partners and families, recognising the diversity of the Australian community.
Conversely, it was not effective for localized prostate cancer, where there was instead a statistically insignificant trend toward reduced overall survival with bicalutamide therapy (at median 7.4 years follow-up: HR Tooltip hazard ratio = 1.16; 95% CI Tooltip confidence interval = 0.99–1.37; P Tooltip p-value = 0.07).
Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Once patients are placed in prognostic categories, this information can contribute to the selection of an optimal approach ...
Ads
related to: simplified hcv treatment algorithm for prostate cancer research charity